118 related articles for article (PubMed ID: 17446070)
1. Synthesis and biological evaluation of nitric oxide-releasing derivatives of oleanolic acid as inhibitors of HepG2 cell apoptosis.
Chen L; Zhang Y; Kong X; Peng S; Tian J
Bioorg Med Chem Lett; 2007 Jun; 17(11):2979-82. PubMed ID: 17446070
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and anti-hepatocellular carcinoma activity of novel O
Zou Y; Yan C; Liu JC; Huang ZJ; Xu JY; Zhou JP; Zhang HB; Zhang YH
Chin J Nat Med; 2017 Dec; 15(12):928-937. PubMed ID: 29329650
[TBL] [Abstract][Full Text] [Related]
3. [Synthesis and biological evaluation of nitrate-oleanolic acid hybrids as inhibitors of HepG2 cell apoptosis].
Chen L; Shang J; Wang ZF; Zhang YH; Tian JD
Yao Xue Xue Bao; 2010 Dec; 45(12):1516-22. PubMed ID: 21351491
[TBL] [Abstract][Full Text] [Related]
4. Hybrid molecule from O2-(2,4-dinitrophenyl)diazeniumdiolate and oleanolic acid: a glutathione S-transferase π-activated nitric oxide prodrug with selective anti-human hepatocellular carcinoma activity and improved stability.
Fu J; Liu L; Huang Z; Lai Y; Ji H; Peng S; Tian J; Zhang Y
J Med Chem; 2013 Jun; 56(11):4641-55. PubMed ID: 23617697
[TBL] [Abstract][Full Text] [Related]
5. Combination of amino acid/dipeptide with nitric oxide donating oleanolic acid derivatives as PepT1 targeting antitumor prodrugs.
Fang L; Wang M; Gou S; Liu X; Zhang H; Cao F
J Med Chem; 2014 Feb; 57(3):1116-20. PubMed ID: 24422538
[TBL] [Abstract][Full Text] [Related]
6. Oleanolic acid-NO donor-platinum(II) trihybrid molecules: Targeting cytotoxicity on hepatoma cells with combined action mode and good safety.
Fang L; Feng M; Chen F; Liu X; Shen H; Zhao J; Gou S
Bioorg Med Chem; 2016 Oct; 24(19):4611-4619. PubMed ID: 27501909
[TBL] [Abstract][Full Text] [Related]
7. [Targeting of nitric oxide-donor and related drugs].
Zhang YH; Tian JD; Peng SX
Yao Xue Xue Bao; 2006 Jun; 41(6):481-6. PubMed ID: 16927819
[No Abstract] [Full Text] [Related]
8. Design, synthesis and cytotoxic evaluation of nitric oxide-releasing derivatives of isosteviol.
Liu Y; Wang T; Ling Y; Bao N; Shi W; Chen L; Sun J
Chem Biol Drug Des; 2017 Sep; 90(3):473-477. PubMed ID: 28122177
[TBL] [Abstract][Full Text] [Related]
9. NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis.
Hatano E; Bennett BL; Manning AM; Qian T; Lemasters JJ; Brenner DA
Gastroenterology; 2001 Apr; 120(5):1251-62. PubMed ID: 11266388
[TBL] [Abstract][Full Text] [Related]
10. Oleanolic acid analogs as NO, TNF-α and IL-1β inhibitors: synthesis, biological evaluation and docking studies.
Bhandari P; Patel NK; Gangwal RP; Sangamwar AT; Bhutani KK
Bioorg Med Chem Lett; 2014 Sep; 24(17):4114-9. PubMed ID: 25113933
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid.
Chen L; Zhang Y; Kong X; Lan E; Huang Z; Peng S; Kaufman DL; Tian J
J Med Chem; 2008 Aug; 51(15):4834-8. PubMed ID: 18598019
[TBL] [Abstract][Full Text] [Related]
12. Glycosylated diazeniumdiolate-based oleanolic acid derivatives: synthesis, in vitro and in vivo biological evaluation as anti-human hepatocellular carcinoma agents.
Huang Z; Fu J; Liu L; Sun Y; Lai Y; Ji H; Knaus EE; Tian J; Zhang Y
Org Biomol Chem; 2012 May; 10(19):3882-91. PubMed ID: 22473516
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and cytotoxic activity of nitric oxide-releasing isosteviol derivatives.
Wang TT; Liu Y; Chen L
Bioorg Med Chem Lett; 2014 May; 24(9):2202-5. PubMed ID: 24685545
[TBL] [Abstract][Full Text] [Related]
14. Novel antileukemic agents derived from tamibarotene and nitric oxide donors.
Bian H; Feng J; Li M; Xu W
Bioorg Med Chem Lett; 2011 Dec; 21(23):7025-9. PubMed ID: 22014829
[TBL] [Abstract][Full Text] [Related]
15. Novel nitric oxide-releasing derivatives of farnesylthiosalicylic acid: synthesis and evaluation of antihepatocellular carcinoma activity.
Ling Y; Ye X; Zhang Z; Zhang Y; Lai Y; Ji H; Peng S; Tian J
J Med Chem; 2011 May; 54(9):3251-9. PubMed ID: 21504204
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of CDDO-amino acid-nitric oxide donor trihybrids as potential antitumor agents against both drug-sensitive and drug-resistant colon cancer.
Ai Y; Kang F; Huang Z; Xue X; Lai Y; Peng S; Tian J; Zhang Y
J Med Chem; 2015 Mar; 58(5):2452-64. PubMed ID: 25675144
[TBL] [Abstract][Full Text] [Related]
17. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-carboxymethylphenyl)-1-(4-methanesulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its aminosulfonyl analog: Synthesis, biological evaluation and nitric oxide release studies.
Abdellatif KR; Chowdhury MA; Dong Y; Das D; Yu G; Velázquez C; Suresh MR; Knaus EE
Bioorg Med Chem; 2009 Jul; 17(14):5182-8. PubMed ID: 19500994
[TBL] [Abstract][Full Text] [Related]
18. A library of 1,2,3-triazole-substituted oleanolic acid derivatives as anticancer agents: design, synthesis, and biological evaluation.
Wei G; Luan W; Wang S; Cui S; Li F; Liu Y; Liu Y; Cheng M
Org Biomol Chem; 2015 Feb; 13(5):1507-14. PubMed ID: 25476168
[TBL] [Abstract][Full Text] [Related]
19. NG, a novel PABA/NO-based oleanolic acid derivative, induces human hepatoma cell apoptosis via a ROS/MAPK-dependent mitochondrial pathway.
Liu L; Fu J; Li T; Cui R; Ling J; Yu X; Ji H; Zhang Y
Eur J Pharmacol; 2012 Sep; 691(1-3):61-8. PubMed ID: 22824464
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of oleanolic acid derivatives as antitumor agents.
Chen L; Wu JB; Lei F; Qian S; Hai L; Wu Y
J Asian Nat Prod Res; 2012; 14(4):355-63. PubMed ID: 22375874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]